Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q2 FY22 results · Jul–Sep 2021
Max Healthcare Institute reported revenue from operations of ₹1,018.33 crore (up 56.4% from Q2 FY21) and net profit of ₹144.65 crore (up 1003.4% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a consolidated basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,018.33 | 650.94 | +56.4% | 1,000.17 | +1.8% |
| Other income | 31.31 | 40.32 | −22.3% | 25.96 | +20.6% |
| Total income | 1,049.64 | 691.26 | +51.8% | 1,026.13 | +2.3% |
| Profit before tax | 181.62 | 17.43 | +942.0% | 189.85 | −4.3% |
| Net profit for the period | 144.65 | 13.11 | 11x | 146.92 | −1.5% |
| EPS, basic (₹) | 1.50 | 0.16 | +837.5% | 1.52 | −1.3% |
| Net margin (%) | 14.2 | 2.0 | 14.7 |
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 449.95 | 281.93 | +59.6% | 500.21 | −10.0% |
| Other income | 28.16 | 31.47 | −10.5% | 27.16 | +3.7% |
| Total income | 478.11 | 313.40 | +52.6% | 527.37 | −9.3% |
| Profit before tax | 95.82 | 10.26 | +833.9% | 114.98 | −16.7% |
| Net profit for the period | 73.25 | 10.43 | +602.3% | 87.92 | −16.7% |
| EPS, basic (₹) | 0.76 | 0.12 | +533.3% | 0.91 | −16.5% |
| Net margin (%) | 16.3 | 3.7 | 17.6 |
Consolidated
- Filed with BSE
- 17 Nov 2021, 01:19 IST
- Board meeting
- 12 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 17 Nov 2021, 01:19 IST
- Board meeting
- 12 Nov 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE